Late-stage trial results show strong reductions
Author: Michael
Scientists, founders, clinicians and consumer he
New machine learning tool turns routine clinic v
Telocyte founder discusses new book and reveals
Human Longevity launches a mobile platform that
Strategic licensing partnership brings fresh cap
Trials begin testing a longer-lasting therapy fo
Celularity Inc.
MBX Biosciences, a clinical‑stage biopharmaceut
Minerva Neurosciences reported its financial resu